Profile
Gregory E.
Papaz is currently the President of Newfield Therapeutics Corp.
He was previously the President & CEO of PAION, Inc. and Senior Vice President-US Commercial Operations at Optimer Pharmaceuticals LLC.
Papaz holds an MBA from Cornell University and an undergraduate degree from Providence College.
Gregory E. Papaz active positions
| Companies | Position | Start |
|---|---|---|
Newfield Therapeutics Corp.
Newfield Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel diagnostic and therapeutic oncological products | President | 31/01/2018 |
Former positions of Gregory E. Papaz
| Companies | Position | End |
|---|---|---|
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Chief Executive Officer | 28/02/2017 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Corporate Officer/Principal | 10/12/2012 |
Training of Gregory E. Papaz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Newfield Therapeutics Corp.
Newfield Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel diagnostic and therapeutic oncological products | Health Technology |
- Stock Market
- Insiders
- Gregory E. Papaz
















